Ituran Location and Control's Q2 Earnings, Revenue Increase-March 2024-www.financetom.com

Ituran Location and Control's Q2 Earnings, Revenue Increase

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Ituran Location and Control's Q2 Earnings, Revenue Increase

Aug 19, 2024 4:30 AM

07:02 AM EDT, 08/19/2024 (MT Newswires) -- Ituran Location and Control ( ITRN ) reported Q2 earnings Monday of $0.66 per diluted share, up from $0.61 a year earlier.

A single analyst polled by CapIQ expected $0.61.

Revenue for the quarter ended June 30 was $84.9 million, compared with $81.6 million a year earlier.

Estimates were not readily available for comparison.

The company maintained a quarterly dividend of $0.39 per share.

Price: 27.80, Change: +0.76, Percent Change: +2.81

Previous page： Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births Next page： SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births

Jul 8, 2024

July 8 (Reuters) - Pfizer's ( PFE ) respiratory syncytial virus (RSV) vaccine for pregnant women was not tied to a higher risk of pre-term or early births, according to a study published on Monday that analyzed real-world use of the shots. The vaccine Abrysvo was approved by the U.S. Food and Drug Administration last year for women in their...

SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio

Jul 8, 2024

10:59 AM EDT, 07/08/2024 (MT Newswires) -- SciSparc ( SPRC ) said Monday it has signed a non-binding letter of intent to spin off its advanced clinical stage pharmaceutical portfolio and its equity stake in SciSparc Nutraceuticals to Miza III Ventures, a publicly traded company on the Toronto Stock Exchange Venture. SciSparc ( SPRC ) said that under the LOI,...

Devon Energy Agrees to Buy Grayson Mill's Williston Basin Business For $5 Billion

Jul 8, 2024

11:01 AM EDT, 07/08/2024 (MT Newswires) -- Devon Energy ( DVN ) announced Monday that it will buy the Williston Basin business of EnCap Investments-backed Grayson Mill Energy in a $5 billion deal that is expected to expand Devon's oil production and drilling inventory. The company will pay $3.25 billion in cash and issue 37 million shares of common stock...

Service Corp, Global Atlantic Form Partnership on Preneed Insurance

Jul 8, 2024

11:03 AM EDT, 07/08/2024 (MT Newswires) -- Global Atlantic Financial Group said Monday it is forming a 10-year partnership with Service Corporation International ( SCI ) to become the preferred provider of preneed insurance for funeral, cremation and cemetery services. Preneed insurance is a type of life insurance policy created to help cover the costs associated with funeral expenses. Price:...